Synthesis of four isotopically labeled forms of a proteasome inhibitor, bortezomib
✍ Scribed by Yuexian Li; Mihaela Plesescu; Patrick Sheehan; J. Scott Daniels; Shimoga R. Prakash
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 117 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
D~2~‐3‐methyl‐1‐[[(2S)‐1‐oxo‐3‐phenyl‐2‐[(pyrazinylcarbonyl)amino]propyl]‐amino]butyl] boronic acid ([D~2~]bortezomib), a proteasome inhibitor, was synthesized in 11 steps from __iso__butyryl chloride. Key steps in the synthesis included formation of the __iso__butyryl boronic acid via Grignard reaction and preparation of the chiral chloride using Matteson reaction. [^13^C~9~]bortezomib, [D~5~]bortezomib, and [D~1~]bortezomib were similarly synthesized from appropriate labeled precursors. Copyright © 2007 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Sodium ring‐[^14^C]‐4‐[[9‐chloro‐7‐(2,6‐difluorophenyl)‐__5H__‐pyrimido[5,4‐__d__][2]benzazepin‐2‐yl]amino]‐benzoate (1A, MLN8054), an Aurora A kinase inhibitor, was synthesized from [^14^C]‐cyanamide in two steps in an overall radiochemical yield of 7%. The intermediate, [^14^C]‐4‐guan
## Abstract Four isotopically (^13^C)‐labeled phenolic acids (caffeic [M + 3], sinapic [M + 2], __p__‐coumaric [M + 6] and ferulic [M + 6] acids) were synthesized via a simple one‐step malonic acid condensation with a series of aldehydes. The aldehydes and the malonic acid were variously labeled an
## Abstract Four racemic nicotine isotopomers, doubly labelled with stable isotope, were prepared for use in studies of plant metabolism. First, starting from halogeno nicotinates, one deuterium was introduced into the pyridine moiety by reductive dehalogenation with zinc, and choosing deuterated a
## Abstract PD0198961 was investigated as a potent and selective inhibitor of coagulation factor Xa for the treatment of thrombotic disorders. Radioactive and stable isotope‐labeled PD0198961 were synthesized for absorption, distribution, metabolism and elimination studies of the compound in animal
## Abstract [(S)‐1′‐((__N__‐__tert__‐Butyloxycarbonyl)amino)‐2S‐[^2^H~5~]phenyl‐ethyl]oxirane __**11**__, made from [^2^H~5~]‐bromobenzene, was transformed into the HIV‐protease inhibitors [^2^H~5~]‐DPH 153893 and [^2^H~5~]‐DPH 140662. Both compounds are members of the hydroxyethylamine class of pr